ATE270893T1 - Sertolizellen als transplantationunterstützer bei zelltransplantationen - Google Patents

Sertolizellen als transplantationunterstützer bei zelltransplantationen

Info

Publication number
ATE270893T1
ATE270893T1 AT96908759T AT96908759T ATE270893T1 AT E270893 T1 ATE270893 T1 AT E270893T1 AT 96908759 T AT96908759 T AT 96908759T AT 96908759 T AT96908759 T AT 96908759T AT E270893 T1 ATE270893 T1 AT E270893T1
Authority
AT
Austria
Prior art keywords
supporter
transplant
sertoli cells
cell transplantations
transplantations
Prior art date
Application number
AT96908759T
Other languages
English (en)
Inventor
Paul R Sanberg
Don F Cameron
Cesario V Borlongan
Richard Heller
Original Assignee
Univ South Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ South Florida filed Critical Univ South Florida
Priority claimed from PCT/US1996/003337 external-priority patent/WO1996028174A1/en
Application granted granted Critical
Publication of ATE270893T1 publication Critical patent/ATE270893T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0681Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0683Cells of the male genital tract, e.g. prostate, epididymis; Non-germinal cells from testis, e.g. Leydig cells, Sertoli cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48Reproductive organs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0618Cells of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/24Genital tract cells, non-germinal cells from gonads
    • C12N2502/246Cells of the male genital tract, non-germinal testis cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Prostheses (AREA)
AT96908759T 1995-03-13 1996-03-12 Sertolizellen als transplantationunterstützer bei zelltransplantationen ATE270893T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/402,387 US5830460A (en) 1995-03-13 1995-03-13 Sertoli cells as transplantation facilitator for cell transplantation
PCT/US1996/003337 WO1996028174A1 (en) 1995-03-13 1996-03-12 Sertoli cells as transplantation facilitator for cell transplantation

Publications (1)

Publication Number Publication Date
ATE270893T1 true ATE270893T1 (de) 2004-07-15

Family

ID=23591668

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96908759T ATE270893T1 (de) 1995-03-13 1996-03-12 Sertolizellen als transplantationunterstützer bei zelltransplantationen

Country Status (10)

Country Link
US (2) US5830460A (de)
JP (1) JPH11509170A (de)
KR (1) KR100297898B1 (de)
AT (1) ATE270893T1 (de)
AU (1) AU709246B2 (de)
CA (1) CA2215303C (de)
DE (1) DE69632905D1 (de)
NZ (1) NZ304647A (de)
TW (1) TW429151B (de)
ZA (1) ZA961973B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6355780B1 (en) * 1995-02-22 2002-03-12 Yeda Research And Development Co. Ltd. Antibodies to the death domain motifs of regulatory proteins
US5830460A (en) 1995-03-13 1998-11-03 University Of South Florida Sertoli cells as transplantation facilitator for cell transplantation
US7399751B2 (en) * 1999-11-04 2008-07-15 Sertoli Technologies, Inc. Production of a biological factor and creation of an immunologically privileged environment using genetically altered Sertoli cells
EP1949904A3 (de) 1999-04-27 2008-08-06 Layton Bioscience, Inc. Zelltherapie für chronische Apoplexie
US20030211085A1 (en) * 2000-03-16 2003-11-13 Sanberg Paul R. Cell therapy for chronic stroke
US6790441B1 (en) 2000-06-13 2004-09-14 University Of South Florida Sertoli cells as biochambers
ATE492636T1 (de) 2002-10-22 2011-01-15 Eisai R&D Man Co Ltd Spezifisch in postmitotischen dopamin- produzierenden neuronalen vorläuferzellen exprimiertes gen
CA2531022C (en) * 2003-07-03 2014-09-09 Jannette Dufour Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants
WO2006118564A2 (en) * 2004-04-29 2006-11-09 Washington State University Research Foundation MODIFIED CELLS EXPRESSING A PROTEIN THAT MODULATES ACTIVITY OF bHLH PROTEINS, AND USES THEREOF
KR101375603B1 (ko) 2004-07-22 2014-04-01 에자이 알앤드디 매니지먼트 가부시키가이샤 Lrp4/Corin 도파민 생산 뉴런 전구 세포 마커
US20070065422A1 (en) * 2005-09-20 2007-03-22 Cameron Don F Induction of immune tolerance by sertoli cells
WO2007119759A1 (ja) 2006-04-11 2007-10-25 Eisai R & D Management Co., Ltd. ドーパミン産生ニューロン前駆細胞マーカー187a5
JP2010500871A (ja) * 2006-07-28 2010-01-14 セルトセル・バイオテクノロジー・(ユーエス)・コーポレイション 成熟セルトリ細胞およびその使用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4829000A (en) 1985-08-30 1989-05-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Reconstituted basement membrane complex with biological activity
DE69133205T2 (de) 1990-10-19 2003-12-11 New York University, New York Eine methode zur transplantation von zellen in das gehirn und ihre therapeutische verwendung
ATE156344T1 (de) 1991-04-25 1997-08-15 Univ Brown Res Found Implantierbare, biokompatible immunisolator- trägersubstanz zum abgeben ausgesuchter, therapeutischer produkte
US5858354A (en) 1991-12-06 1999-01-12 The Trustees Of The University Of Pennsylvania Repopulation of testicular Seminiferous tubules with foreign cells, corresponding resultant germ cells, and corresponding resultant animals and progeny
US5958404A (en) 1994-04-13 1999-09-28 Research Corporation Technologies, Inc. Treatment methods for disease using co-localized cells and Sertoli cells obtained from a cell line
DK0755258T3 (da) 1994-04-13 2002-05-13 Res Corp Technologies Inc Fremgangsmåde til behandling af sygdom ved at anvende Sertoli-celler og allo-transplantater eller xeno-transplantater
US5849285A (en) * 1994-04-13 1998-12-15 Research Corporation Technologies, Inc. Autoimmune disease treatment with sertoli cells and in vitro co-culture of mammal cells with sertoli cells
US5702700A (en) 1995-03-13 1997-12-30 University Of South Florida Sertoli cells as neurorecovery inducing cells for Parkinson's disease
WO1996028174A1 (en) 1995-03-13 1996-09-19 University Of South Florida Sertoli cells as transplantation facilitator for cell transplantation
US5830460A (en) 1995-03-13 1998-11-03 University Of South Florida Sertoli cells as transplantation facilitator for cell transplantation
AU5390696A (en) 1995-04-20 1996-11-07 University Of South Florida Purified and isolated sertoli cell aggregate
US6037175A (en) 1996-03-12 2000-03-14 The University Of South Florida Method and media for enhancing cryopreservation of cells
US6036951A (en) 1996-03-12 2000-03-14 University Of South Florida Sertoli cells as neurorecovery inducing cells for neurodegenerative disorders
US20020065212A1 (en) 1996-11-08 2002-05-30 Selawry Helena P. Methods of treating disease using sertoli cells and allografts or xenografts
US6001643A (en) 1997-08-04 1999-12-14 C-Med Inc. Controlled hydrodynamic cell culture environment for three dimensional tissue growth
US7160724B2 (en) 2000-03-09 2007-01-09 University Of South Florida Human cord blood as a source of neural tissue for repair of the brain and spinal cord
WO2002063938A2 (en) 2000-12-05 2002-08-22 Layton Bioscience Inc. Production and use of dopaminergic cells to treat dopaminergic deficiencies

Also Published As

Publication number Publication date
TW429151B (en) 2001-04-11
AU5189896A (en) 1996-10-02
KR19980703029A (ko) 1998-09-05
US6649160B1 (en) 2003-11-18
KR100297898B1 (ko) 2001-10-25
CA2215303C (en) 2002-02-12
AU709246B2 (en) 1999-08-26
MX9707027A (es) 1998-06-28
NZ304647A (en) 1998-07-28
ZA961973B (en) 1996-09-17
DE69632905D1 (de) 2004-08-19
US5830460A (en) 1998-11-03
CA2215303A1 (en) 1996-09-19
JPH11509170A (ja) 1999-08-17

Similar Documents

Publication Publication Date Title
ATE270893T1 (de) Sertolizellen als transplantationunterstützer bei zelltransplantationen
AU7398691A (en) Human hematopoietic stem cell
ES2160116T3 (es) Modelo de equivalente de cornea producido in vitro.
BR0015148A (pt) Produção androgenética ou ginogenética de linhas de células e células pluripotentes, e seu uso para produzir tecidos e células diferenciados
DK0871414T3 (da) Fremgangsmåder til fremstilling af væv til implantering
CA2390281A1 (en) Hematopoietic differentiation of human embryonic stem cells
GB9215834D0 (en) Cell culture
ZA961597B (en) Method for preparation and transplantation of planar implants and surgical instrument therefor
NZ335383A (en) Epothilone C,D,E and F for plant protection and cytostatic effects shown in kidney cells
WO1995011048A3 (en) METHODS AND COMPOSITIONS OF A BIOARTIFICIAL KIDNEY SUITABLE FOR USE IN VIVO OR $i(EX VIVO)
EP1358895A4 (de) Gewebeäquivalent für die transplantation und verfahren zu seiner herstellung
TR199902184T2 (xx) Sa� nakli y�ntemi
AU3155701A (en) Method and compositions for producing cell transplants
AU1833100A (en) Artificial matrix attachment region for increasing expression of genes introduced in plant cells
NO974239L (no) Sertoliceller som transplantasjonshjelpemidler for celletransplantasjon
AU6424900A (en) Neuronal cell material, use of said material as a transplant and method for producing the same
AU5126596A (en) Use of gelatinase b and related enzymes to mobilize hematopo ietic stem cells for blood stem cell transplantation
GR3031236T3 (en) Process for the preparation of pilocarpine.
RU96120030A (ru) Противолучевое средство
DE69131752D1 (de) Vitalethin und seine anwendung in zellkultur und therapie
JPS6427465A (en) Novel callus inducing cell and production thereof
MX9709748A (es) Uso de lineas celulares fetales neuro-derivadas para terapia de trasplante.
EP1135114A4 (de) Methode zur reduzierung von durch freie radikale induzierte schäden
MX9603788A (es) Equipos para cultivo y transplante de celulas extracorporales.
NO902039L (no) Fremgangsmaate ved dyrking av cellekulturer i bioreaktor.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties